{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:14:53Z","timestamp":1774973693329,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with incidence and mortality projected to rise. Most patients present with advanced or unresectable disease, where treatment efficacy is often constrained by frailty and impaired physical function. As physical function has emerged as a key determinant of treatment eligibility and survival, there is growing interest in physical activity as a supportive intervention in HCC care.<\/jats:p>\n                    <jats:p>This narrative review synthesises observational, pre-clinical, and trial evidence on the role of physical activity in patients with HCC, examining its potential to improve treatment tolerance, quality of life, and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted across four databases (PubMed, Scopus, Web of Science, Embase) using keywords related to HCC, physical activity, exercise, and survivorship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pre-clinical studies reveal multiple mechanisms through which physical activity may enhance anti-tumour responses, including metabolic reprogramming, modulation of oncogenic signalling and immune activation. Observational studies suggest that frailty and sarcopenia - markers of reduced physical function, are possibly associated with early treatment discontinuation and shorter survival in HCC. Preliminary interventional data suggest that structured exercise programmes, delivered in hospital, outpatient, telehealth, or mobile formats, can improve frailty, preserve muscle mass, and may potentially support survival. However, clinical studies to date are limited by small sample sizes, non-randomised designs, and short follow-up periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence provides a biologically plausible and clinically promising rationale for integrating physical activity into HCC care pathways. While findings are encouraging, robust randomised trials are needed to establish efficacy, define optimal exercise regimens, and evaluate long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12029-026-01420-2","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:10:42Z","timestamp":1772676642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Physical Activity and Hepatocellular Carcinoma Outcomes: a Narrative Review of Pre-clinical, Observational, and Interventional Evidence"],"prefix":"10.1007","volume":"57","author":[{"given":"Nadia","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Alcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Del Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen L.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"1","key":"1420_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1420_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3350\/cmh.2023.0070","volume":"29","author":"JH Oh","year":"2023","unstructured":"Oh JH, Jun DW. The latest global burden of liver cancer: A past and present threat. Clin Mol Hepatol. 2023;29(2):355\u20137. https:\/\/doi.org\/10.3350\/cmh.2023.0070.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"1420_CR3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/gutjnl-2023-331695","volume":"73","author":"A Suddle","year":"2024","unstructured":"Suddle A, Reeves H, Hubner R, et al. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults. Gut. 2024;73(8):1235\u201368. . https:\/\/doi.org\/10.1136\/gutjnl-2023-331695","journal-title":"Gut"},{"issue":"10","key":"1420_CR6","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3748\/wjg.v29.i10.1551","volume":"29","author":"W Leowattana","year":"2023","unstructured":"Leowattana W, Leowattana T, Leowattana P. Systemic treatment for unresectable hepatocellular carcinoma. World J Gastroenterol. 2023;29(10):1551\u201368. https:\/\/doi.org\/10.3748\/wjg.v29.i10.1551.","journal-title":"World J Gastroenterol"},{"key":"1420_CR9","doi-asserted-by":"publisher","first-page":"100043","DOI":"10.1016\/j.esmogo.2024.100043","volume":"3","author":"K Waller","year":"2024","unstructured":"Waller K, Prince D, Lai E, et al. The Liver Frailty Index predicts survival in systemic therapy for hepatocellular carcinoma: a multicentre prospective cohort study. ESMO Gastrointest Oncol. 2024;3:100043. https:\/\/doi.org\/10.1016\/j.esmogo.2024.100043.","journal-title":"ESMO Gastrointest Oncol"},{"issue":"23","key":"1420_CR10","doi-asserted-by":"publisher","first-page":"9098","DOI":"10.3390\/ijerph17239098","volume":"17","author":"H Narao","year":"2020","unstructured":"Narao H, Hirota K, Koya S, et al. Effects of in-hospital physical therapy on activities of daily living in patients with hepatocellular carcinoma. Int J Environ Res Public Health. 2020;17(23):9098. https:\/\/doi.org\/10.3390\/ijerph17239098","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"1420_CR11","doi-asserted-by":"publisher","first-page":"e082155","DOI":"10.1136\/bmjopen-2023-082155","volume":"14","author":"K Hallsworth","year":"2024","unstructured":"Hallsworth K, McCain MV, Fallen-Bailey R, et al. Is home-based, virtually delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? (TELEX-Liver Cancer). BMJ Open. 2024;14(6):e082155. https:\/\/doi.org\/10.1136\/bmjopen-2023-082155.","journal-title":"BMJ Open"},{"key":"1420_CR12","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3892\/ol.2020.11345","volume":"19","author":"R Hashida","year":"2020","unstructured":"Hashida R, Kawaguchi T, Koya S, et al. Impact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma. Oncol Lett. 2020;19:2355\u201367. https:\/\/doi.org\/10.3892\/ol.2020.11345.","journal-title":"Oncol Lett"},{"key":"1420_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000941","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao C, Li C, et al. Physical exercise in liver diseases. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000941.","journal-title":"Hepatology"},{"issue":"11","key":"1420_CR14","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3390\/biomedicines12112528","volume":"12","author":"F Casciano","year":"2024","unstructured":"Casciano F, Caruso L, Zauli E, et al. Emerging mechanisms of physical exercise benefits in adjuvant and neoadjuvant cancer immunotherapy. Biomedicines. 2024;12(11):2528. https:\/\/doi.org\/10.3390\/biomedicines12112528.","journal-title":"Biomedicines"},{"issue":"2","key":"1420_CR15","doi-asserted-by":"publisher","first-page":"115234","DOI":"10.1016\/j.celrep.2025.115234","volume":"44","author":"AL Cote","year":"2025","unstructured":"Cote AL, Munger CJ, Ringel AE. Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions. Cell Rep. 2025;44(2):115234. https:\/\/doi.org\/10.1016\/j.celrep.2025.115234.","journal-title":"Cell Rep"},{"issue":"7","key":"1420_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"1420_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1420_CR18","unstructured":"American College of Sports Medicine. ACSM\u2019s Guidelines for Exercise Testing and Prescription. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2014."},{"issue":"5","key":"1420_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/hep4.1159","volume":"2","author":"U Saran","year":"2018","unstructured":"Saran U, Guarino M, Rodr\u00edguez S, et al. Anti-tumoral effects of exercise on hepatocellular carcinoma growth. Hepatol Commun. 2018;2(5):607\u201320. https:\/\/doi.org\/10.1002\/hep4.1159.","journal-title":"Hepatol Commun"},{"key":"1420_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40164-022-00275-0","volume":"11","author":"XF Liu","year":"2022","unstructured":"Liu XF, Zhu XD, Feng LH, et al. Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model. Exp Hematol Oncol. 2022;11:20. https:\/\/doi.org\/10.1186\/s40164-022-00275-0","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"1420_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","volume":"23","author":"L Pedersen","year":"2016","unstructured":"Pedersen L, Idorn M, Olofsson GH, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 2016;23(3):554\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2016.01.011","journal-title":"Cell Metab"},{"key":"1420_CR22","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.12659\/MSM.913377","volume":"25","author":"T Zhao","year":"2019","unstructured":"Zhao T, Fang F, Wang H, et al. Effect of aerobic exercise on serum metabolites in mice with hepatocellular carcinoma after surgery. Med Sci Monit. 2019;25:3181\u20139. https:\/\/doi.org\/10.12659\/MSM.913377.","journal-title":"Med Sci Monit"},{"key":"1420_CR23","doi-asserted-by":"publisher","first-page":"1463655","DOI":"10.3389\/fimmu.2024.1463655","volume":"15","author":"XM You","year":"2024","unstructured":"You XM, Lu FC, Li FR, Zhao FJ, Huo RR. Dynamics trajectory of patient-reported quality of life and associated risk factors among HCC patients receiving immune checkpoint inhibitors: a prospective cohort study. Front Immunol. 2024;15:1463655. https:\/\/doi.org\/10.3389\/fimmu.2024.1463655","journal-title":"Front Immunol"},{"issue":"2","key":"1420_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/cancers13020194","volume":"13","author":"J Tsuchihashi","year":"2021","unstructured":"Tsuchihashi J, Koya S, Hirota K, et al. Effects of in-hospital exercise on frailty in patients with hepatocellular carcinoma. Cancers (Basel). 2021;13(2):194. https:\/\/doi.org\/10.3390\/cancers13020194","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1420_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/ol.2023.13869","volume":"26","author":"J Liu","year":"2023","unstructured":"Liu J, Luo H, Huang L, Wang J. Prevalence of sarcopenia among patients with hepatocellular carcinoma: a systematic review and meta-analysis. Oncol Lett. 2023;26(1):283. https:\/\/doi.org\/10.3892\/ol.2023.13869.","journal-title":"Oncol Lett"},{"issue":"3","key":"1420_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/jgh.14538","volume":"34","author":"S Koya","year":"2019","unstructured":"Koya S, Kawaguchi T, Hashida R, et al. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2019;34(3):580\u20138. https:\/\/doi.org\/10.1111\/jgh.14538.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"1420_CR27","doi-asserted-by":"publisher","first-page":"e14435","DOI":"10.2196\/14435","volume":"8","author":"Y Kim","year":"2020","unstructured":"Kim Y, Seo J, An SY, Sinn DH, Hwang JH. Efficacy and safety of an mHealth app and wearable device in physical performance for patients with hepatocellular carcinoma. JMIR Mhealth Uhealth. 2020;8(3):e14435. https:\/\/doi.org\/10.2196\/14435","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"1420_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1589\/jpts.31.75","volume":"31","author":"RW Bohannon","year":"2019","unstructured":"Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019;31(1):75\u20138. https:\/\/doi.org\/10.1589\/jpts.31.75","journal-title":"J Phys Ther Sci"},{"issue":"10","key":"1420_CR29","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.4187\/respcare.06694","volume":"64","author":"A Zanini","year":"2019","unstructured":"Zanini A, Crisafulli E, D\u2019Andria M, et al. Minimum clinically important difference in 30-s sit-to-stand test after pulmonary rehabilitation in COPD. Respir Care. 2019;64(10):1261\u20139. https:\/\/doi.org\/10.4187\/respcare.06694.","journal-title":"Respir Care"},{"issue":"5","key":"1420_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1532-5415.2006.00701.x","volume":"54","author":"S Perera","year":"2006","unstructured":"Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54(5):743\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2006.00701.x","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1420_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1164\/rccm.201203-0480OC","volume":"186","author":"SC Mathai","year":"2012","unstructured":"Mathai SC, Puhan MA, Lam D, Wise RA. The minimal important difference in the 6-minute walk test for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(5):428\u201333. https:\/\/doi.org\/10.1164\/rccm.201203-0480OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1420_CR32","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365. https:\/\/doi.org\/10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"issue":"2","key":"1420_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024.","journal-title":"J Hepatol"},{"issue":"16","key":"1420_CR34","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3390\/nu14163365","volume":"14","author":"HE Johnston","year":"2022","unstructured":"Johnston HE, Takefala TG, Kelly JT, et al. The effect of diet and exercise interventions on body composition in liver cirrhosis: a systematic review. Nutrients. 2022;14(16):3365. https:\/\/doi.org\/10.3390\/nu14163365","journal-title":"Nutrients"},{"issue":"6","key":"1420_CR35","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1152\/japplphysiol.00798.2019","volume":"128","author":"A Bellar","year":"2020","unstructured":"Bellar A, Welch N, Dasarathy S. Exercise and physical activity in cirrhosis: opportunities or perils. J Appl Physiol (1985). 2020;128(6):1547\u201367. https:\/\/doi.org\/10.1152\/japplphysiol.00798.2019.","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"1420_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.rgmxen.2019.02.013","volume":"84","author":"RU Mac\u00edas-Rodr\u00edguez","year":"2019","unstructured":"Mac\u00edas-Rodr\u00edguez RU, Ruiz-Marg\u00e1in A, Torre A. Exercise prescription in patients with cirrhosis: Recommendations for clinical practice. Rev Gastroenterol Mex (Engl Ed). 2019;84(3):326\u201343. https:\/\/doi.org\/10.1016\/j.rgmxen.2019.02.013.","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"issue":"1","key":"1420_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019.","journal-title":"J Hepatol"},{"issue":"11","key":"1420_CR38","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from an international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375\u201390. https:\/\/doi.org\/10.1249\/MSS.0000000000002116","journal-title":"Med Sci Sports Exerc"},{"key":"1420_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s11938-022-00393-y","volume":"20","author":"\u00c9 Vuille-Lessard","year":"2022","unstructured":"Vuille-Lessard \u00c9, Berzigotti A. Exercise interventions for cirrhosis. Curr Treat Options Gastroenterol. 2022;20:336\u201350. https:\/\/doi.org\/10.1007\/s11938-022-00393-y.","journal-title":"Curr Treat Options Gastroenterol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01420-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01420-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01420-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:10:44Z","timestamp":1772676644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01420-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01420-2","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}